ResearcherHospital Clínic de BarcelonaActive in the last 2 years

Joan Llach

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6535-8925; OpenAlex author ID A5090056809. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 4

Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. Co-author DOI 10.3390/cancers16223779 ↗
Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. Co-author DOI 10.3390/cancers15061690 ↗
Familial Pancreatic Cancer: Current Perspectives. Co-author DOI 10.2147/cmar.s172421 ↗
Genetic Counseling for Hereditary Gastric and Pancreatic Cancer in High-Risk Gastrointestinal Cancer Clinics: An Effective Strategy. Co-author DOI 10.3390/cancers12092386 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Leticia Moreira · 4 shared papers, 2020–2024 · strength 0.59
Fabio Ausania · 2 shared papers, 2023–2024 · strength 0.31
- Paper Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. DOI 10.3390/cancers16223779 ↗
- Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690 ↗
Luís Bujanda · 1 shared paper, 2024 · strength 0.16
- Paper Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. DOI 10.3390/cancers16223779 ↗
Marta Herreros‐Villanueva · 1 shared paper, 2024 · strength 0.16
- Paper Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. DOI 10.3390/cancers16223779 ↗
Julie Earl · 1 shared paper, 2024 · strength 0.16
- Paper Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. DOI 10.3390/cancers16223779 ↗
Glòria Fernández‐Esparrach · 1 shared paper, 2023 · strength 0.15
- Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690 ↗
Àngels Ginés · 1 shared paper, 2023 · strength 0.15
- Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690 ↗
Eva Cristina Vaquero · 1 shared paper, 2023 · strength 0.15
- Paper Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. DOI 10.3390/cancers15061690 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.